Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$175.6 - $291.43 $3.17 Million - $5.26 Million
-18,035 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$174.98 - $272.83 $11,023 - $17,188
63 Added 0.35%
18,035 $3.16 Million
Q3 2020

Nov 13, 2020

SELL
$185.27 - $238.73 $27,049 - $34,854
-146 Reduced 0.81%
17,972 $3.49 Million
Q2 2020

Aug 14, 2020

BUY
$153.32 - $191.72 $158,379 - $198,046
1,033 Added 6.05%
18,118 $3.24 Million
Q4 2019

Feb 19, 2020

BUY
$134.81 - $177.8 $40,173 - $52,984
298 Added 1.78%
17,085 $2.81 Million
Q3 2019

Nov 05, 2019

BUY
$131.82 - $183.4 $2.21 Million - $3.08 Million
16,787 New
16,787 $2.26 Million

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.11B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Mason Street Advisors, LLC Portfolio

Follow Mason Street Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mason Street Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mason Street Advisors, LLC with notifications on news.